mHealth tOol for parkinsOn’s disease training and rehabilitation at Patient’s home

Drittmittelfinanzierte Gruppenförderung - Gesamtprojekt


Details zum Projekt

Projektleiter/in:
Prof. Dr. Björn Eskofier

Projektbeteiligte:
Christine Martindale

Beteiligte FAU-Organisationseinheiten:
Lehrstuhl für Informatik 14 (Maschinelles Lernen und Datenanalytik)

Mittelgeber: EU - 8. Rahmenprogramm - Horizon 2020 (European Institute for Innovation & Technology (EIT))
Akronym: HOOP
Projektstart: 01.02.2018
Projektende: 31.01.2019


Forschungsbereiche

Maschinelles Lernen und Datenanalytik
Lehrstuhl für Informatik 14 (Maschinelles Lernen und Datenanalytik)


Abstract (fachliche Beschreibung):


The HOOP project aims to:



1)       Develop of a universal platform to train PD patients. Parkinson’s disease (PD) patients



repeatedly report great disparities in access to, and quality of, the full range of



Parkinson’s disease services. This represents a social risk for them in terms of access to



medical specialists, caregivers or medical therapy. The value of therapy services in PD



has outlined the importance of having access to these interventions from an early



stage of the disease. A solution which improves the delivery of training to PD patients,



and represents an opportunity to enroll and follow-up, personalized physical therapy



programs at home are important for promoting patient’s long-term engagement and



self-management of their own health.



2)       Improve the quality of life of PD patients through the platform. In addition to the



benefits provided to Parkinson’s patients and according to recent studies showing that



in 2016 a 39,3% of the population in Europe is over 50 years old, which means that



there will be an increase in the mobility and fragility issues due to the aging. In this



sense, it is very important to promote systems and solutions that encourage healthy



living habits with the aim of improving the quality of life.



3)       Provide a final product available and ready for market u p-take. During 2017, HOOP is



being developed from a research laboratory prototype to a semi-commercial product.



Various exploitation plans are being investigated and several potential target markets



related to Parkinson’s disease have shown interest in our product. This means that



HOOP is a mature project, which is close to achieving commercialisation. However, in



order to achieve the latest and most important goals of the project, a commercial



version of the prototype must be finalised, tested and validated. Moreover, the



possibility to extend the target markets would increase the added value of the



product.


Forschungsschwerpunkte der FAU
Medizin, Lebenswissenschaften und Gesundheit


Externe Partner

Universidad Politécnica de Madrid (UPM)
RISE Acreo AB
Centre Expert en Technologies et Servises pour le Maintien en Autonomie a Domicile des Personnes agees (MADoPA)

Zuletzt aktualisiert 2019-07-03 um 13:56